Oxford Immunotec Reports Third Quarter 2015 Financial Results

Go back to Oxford Immunotec Reports Third Quarter 2015 Financial Results

Oxford (OXFD) Tops Q3 EPS by 5c

November 3, 2015 8:39 AM EST

Oxford (NASDAQ: OXFD) reported Q3 EPS of ($0.20), $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $17.9 million versus the consensus estimate of $17.3 million.

Oxford sees Q4 2015 revenue of $15.9-16.7 million, versus the consensus of $17.0 million.

Oxford sees FY2015... More